Where is AstraZeneca Corporate office Headquarters

AstraZeneca Headquarters Address and Contact

Astrazeneca Logo
  • Address: 1 Francis Crick Ave, Cambridge CB2 0RE, UK
  • Phone Number: 44 20 3749 5000
  • Fax Number: N/A
  • Email: N/A
  • Number of Employees: 71,000
  • Established: 1992
  • Founder: N/A
  • Key People: Pascal Soriot (Executive Director & CEO)

AstraZeneca Headquarters Location & Directions

AstraZeneca Headquarters Executive Team



Pascal Soriot

Executive Director & CEO

Marc Dunoyer

Executive Director & CFO

Pam P. Cheng

Executive Vice-President of Operations & Information Technology

About AstraZeneca, History and Headquarters Information

AstraZeneca Pharmaceuticals was incorporated in 1999 after the merger of the two large-scale companies, Swedish Astra AB and the English Zeneca Group. It is headquartered in Cambridge, UK. After the merger, it has come to be known as one of the world's largest pharmaceutical companies. This company made various acquisitions such as Cambridge Antibody Technology in 2006, MedImmune in 2007, Spirogen in 2013 and Definiens by MedImmune in 2014.

AstraZeneca Pharmaceuticals LP is a pharmaceutical and biopharmaceutical company that manufactures drugs. The Company offers a line of products for several therapeutic areas such as cardiovascular and metabolic, gastrointestinal, neuroscience, oncology, respiratory, and infection. AstraZeneca Pharmaceuticals operates globally. AstraZeneca is listed on the London Stock Exchange and on the New York Stock Exchange and the OMX exchange as well. It is also featured on the FTSE 100 Index. As of 2019, they have more than 60,000 people working for them with the target to innovate effective medicines designed to improve the health and quality of life of patients across the globe.

AstraZeneca Headquarters Photos

Rate This
  • Dr. Dr. Hans Schreiber says:

    Astra Zeneca headquarters
    To the hands of the board

    Your cancer research
    Induction of cancer specific apoptosis mechanisms

    Dear Sirs and Madams,

    Sustainable cancer therapy requires new solutions based on new thinking that is fundamentally different from traditional practices.

    With these new methods of thinking, the author can postulate a promising route to sustainable cancer therapy. Hereby, cancer-specific membrane receptors are used for the therapeutic application. It is assumed, and there is much to support this contention, that these cancer-specific membrane receptors have structures that are common to all types of cancer.

    In this respect, the treatment concept is not only applicable for all types of cancer but also for all stages of development and grading. And both primary tumors and metastases appear equally effectively treatable.

    In an effort to understand apoptosis in principle and to reconcile it with the control mechanisms of cell division, the author has succeeded in postulating a therapy concept of cancer via the induction of cancer cell specific apoptosis mechanisms as realizable in a timely manner.

    By the pharmacological bases are already present or require only minor modifications, he can make the audacious statement that in individual cases, the practical implementation of his therapy concepts can succeed within a few months. However, this statement only applies if the following conditions are fulfilled:

    1. In advance, the verification of the underlying complex biochemical processes is omitted and 2. the application is considerated a last resort.

    What seems to be understandable from the needs of the individual cannot be sufficient for routine use. For this the experimental proof is unevitable.

    The undersigned has worked out all experimental setups and solved all logistical problems as far as possible. Accordingly, he can clearly state how the project is to be implemented. In addition, he has already considered or developed the necessary instruments for the serial application of the necessary procedural steps.

    Your company has been dealing with the same problem for many years. So, it is understandable if you pay no attention to these statements. However, before you actually delete this email you should ask yourself if it could not be possible that something fundamentally new is being offered to you.

    Should the sender find your interest with these few lines, he would be pleased to receive a timely response.

    Sincerely yours

    Dr. Hans Schreiber

  • >